In Depth: What’s Next for China’s Covid Vaccine Strategy?

By Zhao Jinzhao and Wang Xintong

2022年11月17日 19:33

Low take-up of first booster doses and a lack of more effective vaccines are the challenges to bolstering immunity, experts say

: In September, China approved two Covid-19 vaccines for emergency use as heterologous boosters — vaccines that are different from the ones people use to complete their primary series of inoculations. Photo: VCG

China’s announcement to “optimize” its Covid strategy on Nov. 11 gave markets reasons to cheer and even led economics professor Liang Jianzhang to predict in a Caixin opinion piece that authorities would consider a full return to its pre-pandemic state.

The latest Covid response put forward 20 new guidelines including ending the “circuit breaker” mechanism for inbound flights and shortening the quarantine period for overseas travelers.

　　[财新双语通产品，是为有双语需求读者专门订制的优惠产品，按此可享超值优惠订阅。]

版面编辑：喻竹杨洋

In Depth: What’s Next for China’s Covid Vaccine Strategy?

推荐阅读

图片推荐

视听推荐

编辑推荐

财新名家

视频

博客

最新文章